125 related articles for article (PubMed ID: 36455131)
1. Immunosuppressive Extracellular Vesicles in CLL.
Zhong W; Guo W
Blood Cancer Discov; 2023 Jan; 4(1):5-7. PubMed ID: 36455131
[TBL] [Abstract][Full Text] [Related]
2. Extracellular Vesicle Secretion by Leukemia Cells In Vivo Promotes CLL Progression by Hampering Antitumor T-cell Responses.
Gargiulo E; Viry E; Morande PE; Largeot A; Gonder S; Xian F; Ioannou N; Benzarti M; Kleine Borgmann FB; Mittelbronn M; Dittmar G; Nazarov PV; Meiser J; Stamatopoulos B; Ramsay AG; Moussay E; Paggetti J
Blood Cancer Discov; 2023 Jan; 4(1):54-77. PubMed ID: 36108149
[TBL] [Abstract][Full Text] [Related]
3. Control of chronic lymphocytic leukemia development by clonally-expanded CD8
Hanna BS; Roessner PM; Yazdanparast H; Colomer D; Campo E; Kugler S; Yosifov D; Stilgenbauer S; Schmidt M; Gabriel R; Lichter P; Seiffert M
Leukemia; 2019 Mar; 33(3):625-637. PubMed ID: 30267008
[TBL] [Abstract][Full Text] [Related]
4. Chronic Lymphocytic Leukemia-Derived IL-10 Suppresses Antitumor Immunity.
Alhakeem SS; McKenna MK; Oben KZ; Noothi SK; Rivas JR; Hildebrandt GC; Fleischman RA; Rangnekar VM; Muthusamy N; Bondada S
J Immunol; 2018 Jun; 200(12):4180-4189. PubMed ID: 29712773
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-10 suppression enhances T-cell antitumor immunity and responses to checkpoint blockade in chronic lymphocytic leukemia.
Rivas JR; Liu Y; Alhakeem SS; Eckenrode JM; Marti F; Collard JP; Zhang Y; Shaaban KA; Muthusamy N; Hildebrandt GC; Fleischman RA; Chen L; Thorson JS; Leggas M; Bondada S
Leukemia; 2021 Nov; 35(11):3188-3200. PubMed ID: 33731852
[TBL] [Abstract][Full Text] [Related]
6. Hanging tough: CMV-specific CD8+ T cells in CLL.
Riches JC; Gribben JG
Blood; 2014 Jan; 123(5):608-9. PubMed ID: 24482498
[TBL] [Abstract][Full Text] [Related]
7. Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemia.
Tinhofer I; Marschitz I; Kos M; Henn T; Egle A; Villunger A; Greil R
Blood; 1998 Jun; 91(11):4273-81. PubMed ID: 9596676
[TBL] [Abstract][Full Text] [Related]
8. EOMES is essential for antitumor activity of CD8
Llaó-Cid L; Roessner PM; Chapaprieta V; Öztürk S; Roider T; Bordas M; Izcue A; Colomer D; Dietrich S; Stilgenbauer S; Hanna B; Martín-Subero JI; Seiffert M
Leukemia; 2021 Nov; 35(11):3152-3162. PubMed ID: 33731848
[TBL] [Abstract][Full Text] [Related]
9. Small extracellular vesicles: multi-faceted tools for leukemia immune evasion
Gargiulo E; Viry E; Moussay E; Paggetti J
Oncoimmunology; 2022; 11(1):2127507. PubMed ID: 36185808
[TBL] [Abstract][Full Text] [Related]
10. Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes.
Mayr C; Bund D; Schlee M; Moosmann A; Kofler DM; Hallek M; Wendtner CM
Blood; 2005 Feb; 105(4):1566-73. PubMed ID: 15471955
[TBL] [Abstract][Full Text] [Related]
11. Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor.
Reinart N; Nguyen PH; Boucas J; Rosen N; Kvasnicka HM; Heukamp L; Rudolph C; Ristovska V; Velmans T; Mueller C; Reiners KS; von Strandmann EP; Krause G; Montesinos-Rongen M; Schlegelberger B; Herling M; Hallek M; Fingerle-Rowson G
Blood; 2013 Jan; 121(5):812-21. PubMed ID: 23118218
[TBL] [Abstract][Full Text] [Related]
12. Select Antitumor Cytotoxic CD8
Baptista MJ; Baskar S; Gaglione EM; Keyvanfar K; Ahn IE; Wiestner A; Sun C
Clin Cancer Res; 2021 Aug; 27(16):4624-4633. PubMed ID: 33875521
[TBL] [Abstract][Full Text] [Related]
13. Blockade of PD-1 and TIM-3 immune checkpoints fails to restore the function of exhausted CD8
Rezazadeh H; Astaneh M; Tehrani M; Hossein-Nataj H; Zaboli E; Shekarriz R; Asgarian-Omran H
Immunol Res; 2020 Oct; 68(5):269-279. PubMed ID: 32710227
[TBL] [Abstract][Full Text] [Related]
14. Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia.
Nishida T; Hudecek M; Kostic A; Bleakley M; Warren EH; Maloney D; Storb R; Riddell SR
Clin Cancer Res; 2009 Jul; 15(14):4759-68. PubMed ID: 19567591
[TBL] [Abstract][Full Text] [Related]
15. Frequency and functional characterization of exhausted CD8
Taghiloo S; Allahmoradi E; Tehrani M; Hossein-Nataj H; Shekarriz R; Janbabaei G; Abediankenari S; Asgarian-Omran H
Eur J Haematol; 2017 Jun; 98(6):622-631. PubMed ID: 28306177
[TBL] [Abstract][Full Text] [Related]
16. PI3Kδ inhibition modulates regulatory and effector T-cell differentiation and function in chronic lymphocytic leukemia.
Hanna BS; Roessner PM; Scheffold A; Jebaraj BMC; Demerdash Y; Öztürk S; Lichter P; Stilgenbauer S; Seiffert M
Leukemia; 2019 Jun; 33(6):1427-1438. PubMed ID: 30573773
[TBL] [Abstract][Full Text] [Related]
17. Clonal expansion within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukemia.
Serrano D; Monteiro J; Allen SL; Kolitz J; Schulman P; Lichtman SM; Buchbinder A; Vinciguerra VP; Chiorazzi N; Gregersen PK
J Immunol; 1997 Feb; 158(3):1482-9. PubMed ID: 9013995
[TBL] [Abstract][Full Text] [Related]
18. Expansion of a CD8(+)PD-1(+) replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progression.
Nunes C; Wong R; Mason M; Fegan C; Man S; Pepper C
Clin Cancer Res; 2012 Feb; 18(3):678-87. PubMed ID: 22190592
[TBL] [Abstract][Full Text] [Related]
19. Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes.
Takahashi S; Rousseau RF; Yotnda P; Mei Z; Dotti G; Rill D; Hurwitz R; Marini F; Andreeff M; Brenner MK
Hum Gene Ther; 2001 Apr; 12(6):659-70. PubMed ID: 11426465
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic alteration of CD8+ T cells in chronic lymphocytic leukemia is associated with epigenetic reprogramming.
Wu J; Xu X; Lee EJ; Shull AY; Pei L; Awan F; Wang X; Choi JH; Deng L; Xin HB; Zhong W; Liang J; Miao Y; Wu Y; Fan L; Li J; Xu W; Shi H
Oncotarget; 2016 Jun; 7(26):40558-40570. PubMed ID: 27302925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]